A. B. Deisseroth - Concepedia

Author

A. B. Deisseroth

The University of Texas MD Anderson Cancer Center

Also Known As

A B Deisseroth, A Deisseroth, A. B. Deisseroth, A. Deisseroth, A.B. Deisseroth, AB DEISSEROTH, AB Deisseroth, ALBERT B. DEISSEROTH

103

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Sidney Kimmel Cancer Center National Cancer Institute National Institutes of Health The University of Texas Health Science Center at San Antonio

About

A. B. Deisseroth is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	29	1.6K
2	Health Sciences	6	6	238
3	Natural Sciences	1	1	37
4	Biomedical Engineering	1	1	32
5	Blood Transplantation	1	1	84

A. B. Deisseroth

Publications

Citations

H-Index

Page 1

	Year	Citations
A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Simon H. Sims, Ying Cha, Margaret F. Romine, Molecular and Cellular Biology GeneticsImmunologyGene PromoterMolecular GeneticsGene Characterization	1993	256
Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups Philip B. McGlave, Paolo de Fabritiis, A. B. Deisseroth, The Lancet Hematological MalignancyAutologous TransplantsTransplantationMarrow TransplantationStem Cell Transplantation	1994	176
Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia P. Liu, HB Hsu, Paula Marlton, Blood	1994	161
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor CF LeMaistre, C Meneghetti, Michael G. Rosenblum, Blood	1992	157
Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF Elihu H. Estey, P. Thall, Hagop M. Kantarjian, Blood	1992	148
A temperature-sensitive mutant of human p53. W. Zhang, Xinyu Guo, Gaoyuan Hu, The EMBO Journal Genome InstabilityHuman P53Molecular BiologyTumor SuppressorCancer Genetics	1994	129
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor CF LeMaistre, C Meneghetti, Michael G. Rosenblum, Blood	1992	127
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia Robert Mashal, M Shtalrid, Moshe Talpaz, Blood	1990	108
High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. W Zhang, Steven M. Kornblau, Takehiko Kobayashi, PubMed Waf1/cip1 GeneMixed-phenotype Acute LeukemiaLeukemia CellsCell CycleCancer Biology	1995	97
Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Juan Fontana, Daniel G. Wright, E Schiffman, Proceedings of the National Academy of Sciences Hematological MalignancyDevelopmental BiologyChemotactic FunctionImmunologyCancer Cell Biology	1980	95

Page 1